6 million Americans have Alzheimer's. By 2050, the total cost of Alzheimer's is expected to surpass 1 trillion dollars. The Center for Medicare & Medicaid Services (@CMSGov) refuses to cover FDA-approved Alzheimer's drug Aduhelm. Why? We demand answers.
This transaction on the Hedera public ledger proves this tweet's content existed and was unaltered as of the consensus timestamp above. Verify independently →